✦ LIBER ✦

722 Comparative Effectiveness of Telaprevir Versus Boceprevir for Genotype 1 Chronic Hepatitis C: An Indirect Pairwise Meta-Analysis

✍ Scribed by Saxena, Akriti P.; Wong, John B.

Book ID: 122173956
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 785 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)63563-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Boceprevir and telaprevir for the treatm

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis

✍ Mills, Edward; Cooper, Curtis; Druyts, Eric; Thorlund, ; Nachega, Jean; El Khour 📂 Article 📅 2012 🏛 Dove Press Ltd. 🌐 English ⚖ 308 KB

1141 BOCEPREVIR OR TELAPREVIR IN COMBINA

1141 BOCEPREVIR OR TELAPREVIR IN COMBINATION WITH PEGINTERFERON FOR HEPATITIS C GENOTYPE 1 INFECTION: AN INDIRECT COMPARISON META-REGRESSION ANALYSIS

✍ Cooper, C.; Druyts, E.; Thorlund, K.; Mills, E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Cost-effectiveness of boceprevir or tela

Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C

✍ Cammà, Calogero; Petta, Salvatore; Cabibbo, Giuseppe; Ruggeri, Matteo; Enea, Mar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Cost-Effectiveness Analysis of Boceprevi

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

✍ Elbasha, Elamin H.; Chhatwal, Jagpreet; Ferrante, Shannon A.; El Khoury, Antoine 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 469 KB

PIN29 Cost Effectiveness Analysis of Add

PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

✍ Ramachandran, S.; Mahabaleshwarkar, R.; Yang, Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Cost Effectiveness Analysis of Boceprevi

Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

✍ Athanasakis, K.; Karampli, E.; Retsa, M.P.; Theodoropoulou, T.; Kyriopoulos, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB